FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

ValueSets, Realm US

12,841 resources

Source: Text:

By Version

By Authority

  • none: 1,981
  • hl7: 10,860

 

Start Prev Rows 12400 - 12600 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuthSource(s)
us.nlm.vsacR42.16.840.1.113762.1.4.1235.439bwell_Vital_Diastolic Blood Pressure_LOINCactive2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.511bwell_Vital_Diastolic Blood Pressure_SNOMEDactive2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1235.512bwell_Vital_Systolic Blood Pressure_SNOMEDactive2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1235.513bwell_Vital_Systolic_and_Diastolic Blood Pressure_LOINCactive2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.442bwell_Vital_Body Fat_LOINCactive2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.444bwell_Vital_Body Height_LOINCactive2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.445bwell_Vital_Body Weight_LOINCactive2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.535bwell_Vital_Body Surface Area_LOINCactive2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.536bwell_Vital_Body Surface Area_SNOMEDactive2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1235.443bwell_Vital_Body Temperature_LOINCactive2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.510bwell_Vital_Body Temperature_SNOMEDactive2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1235.532bwell_Vital_Head Circumference_LOINCactive2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.533bwell_Vital_Head Circumference_SNOMEDactive2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1235.440bwell_Vital_Heart Rate_LOINCactive2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.515bwell_Vital_Heart Rate_SNOMEDactive2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1235.446bwell_Vital_Respiratory Rate_LOINCactive2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.516bwell_Vital_Respiratory Rate_SNOMEDactive2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1235.538bwell_Vital_Vital Signs Panel_LOINCactive2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.539bwell_Vital_Vital Signs Panel_CPTactive2025-02hl7cpt
us.nlm.vsacR42.16.840.1.113762.1.4.1235.447bwell_Vital_Waist Circumference_LOINCactive2025-02hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1235.508bwell_Vital_Waist Circumference_SNOMEDactive2025-02hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1235.5ADD/ADHD Conditionactive2025-02hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.344AFib (Atrial Fibrillation)_Clinical Condition Groupingactive2023-08hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.500Active Pregnancy_Clinical Grouping Eventactive2024-04hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.362Allergy List_Clinical Grouping Eventactive2023-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.20Annual Physical CN5active2023-04hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.436Anxiety_Clinical Grouping Conditionactive2024-04hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.253Asthma_Clinical Condition Groupingactive2023-05hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.424BMI >=30_Event_Clinical Condition Groupingactive2024-04hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.393BMI >=40_Event_Clinical Condition Groupingactive2024-04hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.453bwell_Vital_BMI_Clinical Grouping Eventactive2024-05hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.450bwell_Vital_Systolic Blood Pressure_Clinical Grouping Eventactive2024-06hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.413Birth Event_Clinical Grouping Eventactive2024-01hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.448bwell_Vital_Blood Glucose_Clinical Grouping Labactive2024-05hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.449bwell_Vital_Blood Oxygen_Clinical Grouping Eventactive2024-06hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.186Acute Inpatient_HD_Groupingactive2023-01hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.190Pregnancy_HD_Groupingactive2024-04hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.193ED Visit_HD_Groupingactive2023-01hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.542bwell_Vital_Blood Pressure Panel_Clinical Grouping Eventactive2024-08hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.454bwell_Vital_Body Fat_Clinical Grouping Eventactive2024-05hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.456bwell_Vital_Body Height_Clinical Grouping Eventactive2024-05hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.537bwell_Vital_Body Surface Area_Clinical Grouping Eventactive2024-08hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.455bwell_Vital_Body Temperature_Clinical Grouping Eventactive2024-06hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.457bwell_Vital_Body Weight_Clinical Grouping Eventactive2024-05hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.514bwell_Vital_Systolic_and_Diastolic Blood Pressure_Clinical Grouping Eventactive2024-06hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.558CABG_Clinical Grouping Conditionactive2024-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.588COPD_Clinical Condition Groupingactive2025-02hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.350COVID19 Vaccine_Event Clinical Groupingactive2023-08hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.375Cirrhosis_Groupingactive2023-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.318Colorectal Cancer_HD_Groupingactive2023-05hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.606Diastolic Blood Pressure_Compliantactive2025-02hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.605Systolic Blood Pressure_Compliantactive2025-02hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.359Coronary Artery Disease (CAD)_Clinical Condition Groupingactive2023-08hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.549Depression_Clinical Grouping Conditionactive2024-08hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.180Diastolic Blood Pressure_HDactive2023-01hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.182Remote Blood Pressure_HDactive2023-01hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.451bwell_Vital_Diastolic Blood Pressure_Clinical Grouping Eventactive2024-06hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.584Diastolic Less than 90_HD_Clinical Grouping Eventactive2024-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.94Cardiomyopathy Dilated Conditionactive2025-02hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.172End Stage Renal Disease (ESRD)_HD_Clinical Condition Groupingactive2023-01hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.567Essential HTN_HD_Clinical Grouping Conditionactive2024-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.571Total and Partial Neph_HD_Clinical Grouping Conditionactive2024-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.385Family History Hypertension (HTN)_Clinical Condition Groupingactive2024-05hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.406First Trimester_Clinical Grouping Eventactive2024-02hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.207Bone Marrow Transplant_HD_CN_Groupingactive2023-01hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.211Immunocompromising Conditions_HD_CN_Groupingactive2023-01hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.215Cerebrospinal Fluid Leak_HD_CN_Groupingactive2023-01hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.219Anatomic or Functional Asplenia_HD_CN_Groupingactive2023-01hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.222Sickle cell Anemia and HB S Disease_HD_CN_Groupingactive2023-01hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.237Cochlear Implant_HD_CN_Groupingactive2023-01hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.241Chemotherapy_HD_CN_Groupingactive2023-01hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.580HbA1c Level Less Than 8.0_HD_Clinical Grouping Conditionactive2024-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.534bwell_Vital_Head Circumference_Clinical Grouping Eventactive2024-08hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.265Heart Failure (CHF)_Clinical Condition Groupingactive2023-05hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.452bwell_Vital_Heart Rate_Clinical Grouping Eventactive2024-06hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.100Cardiomyopathy Hypertrophic Conditionactive2025-03hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.378IVF_Groupingactive2023-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.232Influenza Vaccine_HD_CN_Groupingactive2023-01hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.369Ischemic Vascular Disease (IVD)_Groupingactive2023-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.578Kid Trans and Hx_HD_Clinical Grouping Conditionactive2024-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.198Lipid Panel_Event_Groupingactive2023-01hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.520Lupus_Clinical Condition Groupingactive2025-03hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.553MI (Myocardial Infarction)_Clinical Grouping Conditionactive2024-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.372Muscular Pain and Disease_Groupingactive2023-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.417Obesity_Clinical Grouping Conditionactive2024-04hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.366Other Revascularization_Groupingactive2023-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.564PCI (Percutaneous Coronary Intervention)_Clinical Grouping Conditionactive2024-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.227Pneumococcal Vaccine_HD_CN_Groupingactive2023-01hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.593Polypharmacy_Clinical Condition Groupingactive2025-02hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.531Postpartum_Clinical Grouping Eventactive2024-08hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.382Pre_Hypertension (Pre_HTN)_Clinical Condition Groupingactive2024-04hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.504Prediabetes_Clinical Grouping Conditionactive2024-08hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.257Pregnancy Loss_HD_Clinical Condition Groupingactive2023-05hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.458bwell_Vital_Respiratory Rate_Clinical Grouping Eventactive2024-06hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.465Second Trimester_Clinical Grouping Eventactive2024-03hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.400Smoker Status_Event_Clinical Condition Groupingactive2024-04hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.176Systolic Blood Pressure_HDactive2023-01hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.583Systolic Less than 140_HD_Clinical Grouping Eventactive2024-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.468Third Trimester_Clinical Grouping Eventactive2024-04hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.204Unknown Glucose_Lab_Groupingactive2023-01hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.524UTI_Clinical Condition Groupingactive2024-06hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.540bwell_Vital_Vital Signs Panel_Clinical Grouping Eventactive2025-02hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.459bwell_Vital_Waist Circumference_Clinical Grouping Eventactive2024-06hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.617bwell Combo Blood Pressure_UIactive2025-02hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.616bwell Diastolic Blood Pressure_UIactive2025-02hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.615bwell Systolic Blood Pressure_UIactive2025-02hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.626b.well Herpes Zoster Vaccine CN_HD_Exclusionsactive2025-03hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.627b.well Herpes Zoster Vaccine CN_HD_Exclusions_SNOMEDactive2025-03hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1235.625b.well Herpes Zoster Vaccine CN_HD_2dose_SNOMEDactive2025-03hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1235.622b.well Herpes Zoster Vaccine CN_HD_2doseactive2025-03hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.618b.well Herpes Zoster Vaccine CN_HDactive2025-03hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1196.1358Beta lactam medicinal product SNOMEDactive2024-05hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.224Systolic Heart Failure I10active2025-03hl7icd
us.cdc.phinvadsR42.16.840.1.114222.4.11.7106VPD Specimen Source Body Siteactive2014-01sct
us.nlm.vsacR42.16.840.1.113762.1.4.1235.647bwell Covid Vaccine CN_Allergy_SNOMEDactive2025-04hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1196.1354Cefixime preparations for oral administrationactive2024-05hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1ONC Administrative Sexactive2015-03hl7tho
us.nlm.vsacR42.16.840.1.113762.1.4.1196.1352Body weightactive2024-05hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1260.58MMR Deficientactive2023-11hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1260.59MMR Deficientactive2024-01hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1260.60MMR Deficientactive2024-01hl7vsac
us.cdc.phinvadsR42.16.840.1.114222.4.11.5022Original Specimen Source Site Modifier PHLIPactive2011-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.5023Original Specimen Collection Method PHLIPactive2011-01sct
us.cdc.phinvadsR42.16.840.1.11222.4.11.5025Original Specimen Type Modifier PHLIPactive2011-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.5001Specimen Type PHLIPactive2011-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.5024Original Specimen Type PHLIPactive2011-01sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1083Central DXA of Hip or Spineactive2018-03hl7loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.5016Organization Unit (PHLIP)active2011-01oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7794LikelyAte (Listeria)active2018-01tho oid
us.nlm.vsacR42.16.840.1.113762.1.4.1196.4467Urogenital & Anorectal Specimensactive2024-05hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1166.87Intrauterine Devices SNOMED Findingsactive2021-10hl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.199.11.1065Chronic Liver Diseaseactive2024-02hl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.199.11.1067Chronic Liver Diseaseactive2022-01hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1196.4466Pharyngeal specimensactive2024-05hl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1097Marfan's Syndromeactive2022-02hl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.117.12.1009Cushings Syndromeactive2024-01hl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1085Osteogenesis Imperfectaactive2022-02hl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1087Osteogenesis Imperfectaactive2018-03hl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1088Ankylosing Spondylitisactive2021-02hl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1090Ankylosing Spondylitisactive2018-03hl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1091Psoriatic Arthritisactive2018-03hl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1093Psoriatic Arthritisactive2018-03hl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1096Ehlers Danlos Syndromeactive2022-02hl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1099Marfan's Syndromeactive2018-03hl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1100Osteopeniaactive2018-08hl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1102Osteopeniaactive2018-03hl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.12.1044Osteogenesis Imperfectaactive2024-01hl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.12.1045Ankylosing Spondylitisactive2023-12hl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.12.1046Psoriatic Arthritisactive2024-01hl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.12.1048Marfan's Syndromeactive2024-01hl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.12.1049Osteopeniaactive2024-01hl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.117.11.1023Cushings Syndromeactive2021-03hl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.117.11.1025Cushings Syndromeactive2018-03hl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.117.11.1026Lupusactive2023-02hl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.117.11.1028Lupusactive2018-03hl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.117.12.1010Lupusactive2024-01hl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.199.11.1068Chronic Malnutritionactive2023-02hl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.199.11.1070Chronic Malnutritionactive2018-03hl7icd
us.nlm.vsacR42.16.840.1.113883.3.464.1003.199.12.1036Chronic Malnutritionactive2024-01hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1021.120Patient Sex for Quality Measurementactive2024-10hl7vsac
us.nlm.vsacR42.16.840.1.113883.3.464.1003.199.12.1035Chronic Liver Diseaseactive2024-01hl7vsac
us.cdc.phinvadsR42.16.840.1.114222.4.11.3289Vaccination Reaction and Adverse Event (IIS)active2012-01sct oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.4028Lab Result (Ebolavirus)active2015-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4000Lab Result (Amebiasis)active2017-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4001Lab Result (Anaplasma)active2015-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4002Lab Result (Anthrax)active2011-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4003Lab Result (Arbovirus)active2011-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4004Lab Result (Arenavirus)active2011-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4005Lab Result (Babesiosis)active2015-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.4006Lab Result (Bartonellosis)active2018-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4007Lab Result (Blastomycosis)active2018-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4008Lab Result (Botulism)active2017-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4009Lab Result (Brucellosis)active2015-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4010Lab Result (California serogroup virus)active2011-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4011Lab Result (Campylobacteriosis)active2019-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4012Lab Result (Chagas)active2015-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4013Lab Result (Chancroid)active2011-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4014Lab Result (Chlamydia trachomatis)active2015-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4015Lab Result (Cholera)active2011-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4016Lab Result (Clostridium perfringens)active2011-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4017Lab Result (Clostridium perfringens Epsilon Toxin)active2011-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4018Lab Result (Coccidioidomycosis)active2015-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4019Lab Result (Colorado Tick Fever)active2011-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4020Lab Result (Creutzfeldt-Jakob disease)active2011-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4021Lab Result (Cryptococcosis)active2019-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4022Lab Result (Cryptosporidiosis)active2015-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4023Lab Result (Cyclosporiasis)active2011-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4025Lab Result (Dengue)active2011-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4026Lab Result (Diphtheria)active2017-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4029Lab Result (E. coli STEC)active2019-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4027Lab Result (Eastern equine encephalitis virus)active2011-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4030Lab Result (Ehrlichia chaffeensis)active2011-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4031Lab Result (Ehrlichia ewingii)active2011-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4032Lab Result (Ehrlichiosis Anaplasmosis)active2015-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4033Lab Result (Genital Warts)active2011-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4034Lab Result (Giardiasis)active2017-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4035Lab Result (Glanders)active2011-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4036Lab Result (Gonorrhea)active2015-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4037Lab Result (Granuloma Inguinale)active2011-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.4049Lab Result (HIV)active2011-01sct